Live Breaking News & Updates on Epilepsy Clinical Lead
Stay updated with breaking news from Epilepsy clinical lead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biohaven reported full results from the BHV-7000 Phase 1 study examining doses up to 120 mg daily, demonstrating BHV-7000 was well-tolerated at all doses. ....